[go: up one dir, main page]

NO20002787D0 - New connections - Google Patents

New connections

Info

Publication number
NO20002787D0
NO20002787D0 NO20002787A NO20002787A NO20002787D0 NO 20002787 D0 NO20002787 D0 NO 20002787D0 NO 20002787 A NO20002787 A NO 20002787A NO 20002787 A NO20002787 A NO 20002787A NO 20002787 D0 NO20002787 D0 NO 20002787D0
Authority
NO
Norway
Prior art keywords
new connections
connections
new
Prior art date
Application number
NO20002787A
Other languages
Norwegian (no)
Other versions
NO20002787L (en
Inventor
Andrew Baxter
David Cheshire
Thomas Mcinally
Michael Mortimore
David Cladingboel
Original Assignee
Astrazeneca Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd
Publication of NO20002787D0 publication Critical patent/NO20002787D0/en
Publication of NO20002787L publication Critical patent/NO20002787L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20002787A 1997-12-05 2000-05-31 New connections NO20002787L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704546A SE9704546D0 (en) 1997-12-05 1997-12-05 Novel compounds
PCT/SE1998/002190 WO1999029686A1 (en) 1997-12-05 1998-12-01 Novel compounds

Publications (2)

Publication Number Publication Date
NO20002787D0 true NO20002787D0 (en) 2000-05-31
NO20002787L NO20002787L (en) 2000-08-01

Family

ID=20409283

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002787A NO20002787L (en) 1997-12-05 2000-05-31 New connections

Country Status (16)

Country Link
EP (1) EP1037889A1 (en)
JP (1) JP2001525406A (en)
KR (1) KR20010032800A (en)
CN (1) CN1284074A (en)
AU (1) AU1791599A (en)
BR (1) BR9813378A (en)
CA (1) CA2312357A1 (en)
EE (1) EE200000321A (en)
HU (1) HUP0100731A3 (en)
IL (1) IL136368A0 (en)
NO (1) NO20002787L (en)
PL (1) PL340837A1 (en)
SE (1) SE9704546D0 (en)
SK (1) SK8442000A3 (en)
TR (1) TR200001544T2 (en)
WO (1) WO1999029686A1 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901875D0 (en) * 1999-05-25 1999-05-25 Astra Pharma Prod Novel compounds
SE9904505D0 (en) 1999-12-09 1999-12-09 Astra Pharma Prod Novel compounds
TWI258462B (en) 1999-12-17 2006-07-21 Astrazeneca Ab Adamantane derivative compounds, process for preparing the same and pharmaceutical composition comprising the same
SE9904652D0 (en) * 1999-12-17 1999-12-17 Astra Pharma Prod Novel Compounds
JP2002330787A (en) * 2000-10-21 2002-11-19 Astrazeneca Ab Chemical substance
PA8557501A1 (en) 2001-11-12 2003-06-30 Pfizer Prod Inc BENZAMIDA, HETEROARILAMIDA AND INVESTED AMIDAS
WO2003042190A1 (en) 2001-11-12 2003-05-22 Pfizer Products Inc. N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
US7071223B1 (en) 2002-12-31 2006-07-04 Pfizer, Inc. Benzamide inhibitors of the P2X7 receptor
PA8591801A1 (en) 2002-12-31 2004-07-26 Pfizer Prod Inc BENZAMID INHIBITORS OF THE P2X7 RECEIVER.
WO2004099146A1 (en) 2003-05-12 2004-11-18 Pfizer Products Inc. Benzamide inhibitors of the p2x7 receptor
GB0324498D0 (en) 2003-07-21 2003-11-26 Aventis Pharma Inc Heterocyclic compounds as P2X7 ion channel blockers
RU2006146675A (en) 2004-06-29 2008-07-10 Пфайзер Продактс Инк. (Us) METHOD FOR PRODUCING 5- [4- (2-HYDROXYPROPYL) -3,5-DIOXO-4,5-DIHYDRO-3H- [1,2,4] TRIAZIN-2-IL] BENZAMIDE DERIVATIVES BY REMOVING PROTECTION FROM INTERMEDIATE PRODUCTS, SODA HYDROXYL
TWI464148B (en) 2006-03-16 2014-12-11 Evotec Us Inc Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
MX2008011919A (en) 2006-03-16 2008-11-28 Renovis Inc Bicycloheteroaryl compounds as p2x7 modulators and uses thereof.
ES2569677T3 (en) 2006-03-16 2016-05-12 Second Genome, Inc. Bicycloheteroaryl compounds as modulators of P2X7 and uses thereof
TW200813018A (en) 2006-06-09 2008-03-16 Astrazeneca Ab Novel compounds
PL2049478T3 (en) * 2006-07-06 2012-09-28 Glaxo Group Ltd Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use
GB0613473D0 (en) * 2006-07-06 2006-08-16 Glaxo Group Ltd Novel compounds
CA2680275C (en) 2007-03-09 2016-08-23 Renovis, Inc. Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
US20100168171A1 (en) * 2007-03-28 2010-07-01 Paul John Beswick Piperidinone Carboxamide Derivatives as P2X7 Modulators
US20100144727A1 (en) * 2007-03-29 2010-06-10 Paul John Beswick Oxazolidine and Morpholine Carboxamide Derivatives as P2X7 Modulators
WO2008119825A2 (en) 2007-04-03 2008-10-09 Glaxo Group Limited Imidazolidine carboxamide derivatives as p2x7 modulators
US8119661B2 (en) 2007-09-11 2012-02-21 Astrazeneca Ab Piperidine derivatives and their use as muscarinic receptor modulators
GB0803729D0 (en) * 2008-02-29 2008-04-09 Ge Healthcare Ltd Imaging the central nervous system
JP5506776B2 (en) 2008-03-25 2014-05-28 アフェクティス ファーマシューティカルズ アーゲー Novel P2X7R antagonist and use thereof
WO2010118921A1 (en) 2009-04-14 2010-10-21 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
EP2322149A1 (en) 2009-11-03 2011-05-18 Universidad del Pais Vasco Methods and compositions for the treatment of ischemia
EA201201548A1 (en) 2010-05-14 2013-05-30 Эффектис Фармасьютиклз Аг NEW WAYS TO GET P2X7R ANTAGONISTS
WO2012110190A1 (en) 2011-02-17 2012-08-23 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2012163456A1 (en) 2011-05-27 2012-12-06 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2012163792A1 (en) 2011-05-27 2012-12-06 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
EP3713540B1 (en) 2017-11-21 2025-08-20 Solventum Intellectual Properties Company Plant based oil-in-water oral emulsions and methods of use
JP7341143B2 (en) 2017-12-20 2023-09-08 スリーエム イノベイティブ プロパティズ カンパニー Oral composition and method of use
US11324681B2 (en) 2017-12-20 2022-05-10 3M Innovative Properties Company Oral compositions and methods of use
CN113226287B (en) 2018-12-29 2025-10-17 舒万诺知识产权公司 Oral product and method of use

Also Published As

Publication number Publication date
AU1791599A (en) 1999-06-28
HUP0100731A3 (en) 2002-08-28
SE9704546D0 (en) 1997-12-05
KR20010032800A (en) 2001-04-25
IL136368A0 (en) 2001-06-14
EP1037889A1 (en) 2000-09-27
JP2001525406A (en) 2001-12-11
SK8442000A3 (en) 2001-01-18
CN1284074A (en) 2001-02-14
NO20002787L (en) 2000-08-01
WO1999029686A1 (en) 1999-06-17
PL340837A1 (en) 2001-02-26
EE200000321A (en) 2001-08-15
HUP0100731A2 (en) 2002-05-29
CA2312357A1 (en) 1999-06-17
TR200001544T2 (en) 2000-11-21
BR9813378A (en) 2000-10-10

Similar Documents

Publication Publication Date Title
NO20000312L (en) New connections
NO20002787D0 (en) New connections
NO970374L (en) New connections
NO20001938D0 (en) New aryloxy-alkyl-dialkylamines
NO973231D0 (en) New connections
NO960472L (en) New connections
DK0973746T3 (en) Substituted 3-cyanoquinolines
NO970512D0 (en) Novel heteroaryl-oxazolidinones
ID24329A (en) MOBILE-FLOOR FOUNDATION
DK0906288T3 (en) New connections
NO20010860D0 (en) New connections
DK1025107T3 (en) Photochromic connections
PT1036083E (en) NEW 9A-AZALIDOS
NO20010861D0 (en) New connections
DE59813487D1 (en) SUBSTITUTED 4-BENZOYL-PYRAZOLE
DK0983266T3 (en) New tetrahydrosioquinolinthiophenecarboximidamides
NO990072D0 (en) New connections
NO20010584L (en) New connections
ATE244705T1 (en) SUBSTITUTED 4-BENZOYL-PYRAZOLES
NO20011262D0 (en) New connections
DE59807877D1 (en) SUBSTITUTED 4-BENZOYL-PYRAZOLE
ID24079A (en) AMINOHETEROXICLYLAMIDE SUBSTITUTED
NO983505D0 (en) New phenanthrides
DE69739606D1 (en) ITS CONNECTIONS
DE59810960D1 (en) SUBSTITUTED PHENYLURACILE

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application